SpringWorks Therapeutics, Inc(NASDAQ:SWTX) 
SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company, acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that ...
Website: http://www.springworkstx.com
Founded: 2017
Full Time Employees: 71
CEO: Saqib Islam
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-12-30
P
O 35.95
H 36.93
L 35.39
C 36.34
V 703,392
10EMA 36.34
20EMA 36.34
60EMA 36.34
120EMA 36.34
250EMA 36.34